New England IRB is an independent institutional review board for multi-site studies and individual researchers. New England IRB is national in scope and provides ethical review services for Sponsors, CROs and investigators throughout the United States.
New England IRB reviews:
All Phases of FDA regulated clinical trials:
Phase 0
Phase I
Phase II
Phase III
Phase IV
Drug, Device, and Biologic studies
Registry studies
Socio-Behavioral, and Educational studies
Peri-approval and post-approval studies
Request for Exemption
Founded in 1988, New England IRB was one of the first central IRBs established to meet the ethical review needs of a burgeoning drug development market. Our boards are comprised of highly qualified members with significant experience and knowledge in the scientific, legal, and ethical aspects of clinical trials.
From single site studies to several thousand site studies, New England IRB consistently provides a seamless ethical review process that allows sponsors and CROs to focus their efforts on other priorities. A professional and responsive administrative staff is focused on service, providing an efficient and cost effective review process.
New England IRB understands the importance of timely review. With three review Boards, our standard is to review new protocols within one week of receipt of the complete application. Site reviews are completed within 24 – 48 hours, regardless of the day of the week they are received. In both cases, overnight notification is dispatched the next day.
|
New England IRB has been audited by the United States Food and Drug Administration, and found to be in compliance with regulations. We have also served as the IRB for federally funded research. Because New England IRB is affiliated with the Commonwealth of Massachusetts' Department of Public Health, a requirement for reviewing research in Massachusetts, we are able to review studies in all 50 states.
Please call New England IRB, if you would like to arrange for a review. If you need further information, please feel free to call (781-431-7577).
|
